Lung gene expression signatures suggest pathogenic links and molecular markers for pulmonary tuberculosis, adenocarcinoma and sarcoidosis.
Qiyao ChaiZhe LuZhidong LiuYanzhao ZhongFuzhen ZhangChanggen QiuBingxi LiJing WangLingqiang ZhangYu PangCui Hua LiuPublished in: Communications biology (2020)
Previous reports have suggested a link between pulmonary tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb), and the development of lung adenocarcinoma (LUAD) and sarcoidosis. Furthermore, these lung diseases share certain clinical similarities that can challenge differential diagnosis in some cases. Here, through comparison of lung transcriptome-derived molecular signatures of TB, LUAD and sarcoidosis patients, we identify certain shared disease-related expression patterns. We also demonstrate that MKI67, an over-expressed gene shared by TB and LUAD, is a key mediator in Mtb-promoted tumor cell proliferation, migration, and invasion. Moreover, we reveal a distinct ossification-related TB lung signature, which may be associated with the activation of the BMP/SMAD/RUNX2 pathway in Mtb-infected macrophages that can restrain mycobacterial survival and promote osteogenic differentiation of mesenchymal stem cells. Taken together, these findings provide novel pathogenic links and potential molecular markers for better understanding and differential diagnosis of pulmonary TB, LUAD and sarcoidosis.
Keyphrases
- mycobacterium tuberculosis
- pulmonary tuberculosis
- genome wide
- gene expression
- mesenchymal stem cells
- cell proliferation
- dna methylation
- squamous cell carcinoma
- ejection fraction
- newly diagnosed
- single cell
- bone marrow
- epithelial mesenchymal transition
- emergency department
- radiation therapy
- transcription factor
- umbilical cord
- single molecule
- cell cycle
- risk assessment
- rna seq
- chronic kidney disease
- cell therapy
- transforming growth factor
- patient reported outcomes